Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells

Cancer Cell International

Volumn 3, Issue , 2003, Pages

  Jiang, Hong ^a   Coleman, Jennifer ^a   Miskimins, Robin ^a   Miskimins, W Keith ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; MESSENGER RNA; PROTEIN P27; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRANSLATION REGULATION; UPREGULATION;

EID: 2942515128     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-3-2     Document Type: Article

References (38)

1. Hiremath LS, Webb NR and Rhoads RE Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 1985, 260:7843-7849
2. Duncan R, Milburn SC and Hershey JW Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 1987, 262:380-388
3. Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, Callanan L and Schmidt EV An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by cmyc. Mol Cell Biol 1996, 16:4754-4764
4. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T and Sonenberg N Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J 1999, 18:270-279
5. Waskiewicz AJ, Johnson JC, Penn B, Mahalingam M, Kimball SR and Cooper JA Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo. Mol Cell Biol 1999, 19:1871-1880
6. Wang X, Flynn A, Waskiewicz AJ, Webb BL, Vries RG, Baines IA, Cooper JA and Proud CG The phosphorylation of eukaryotic initiation factor eIF4E in response to phorbol esters, cell stresses, and cytokines is mediated by distinct MAP kinase pathways. J Biol Chem 1998, 273:9373-9377
7. Haghighat A, Mader S, Pause A and Sonenberg N Repression of capdependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 1995, 14:5701-5709
8. Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr and Sonenberg N Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 1994, 371:762-767
9. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I and Avruch J Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 1997, 272:26457-26463
10. von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N and Thomas G The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol Cell Biol 1997, 17:5426-5436
11. Brunn GJ, Hudson CC, Sekulic A, Williams JM, Hosoi H, Houghton PJ, Lawrence JC Jr and Abraham RT Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 1997, 277:99-101
12. Lazaris-Karatzas A, Montine KS and Sonenberg N Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990, 345:544-547
13. Lazaris-Karatzas A and Sonenberg N The mRNA 5′ cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 1992, 12:1234-1238
14. De Benedetti A, Joshi B, Graff JR and Zimmer SG CHO cells transformed by the translation factor eIF4E display increased cmyc expression but require overexpression of Max for tumorigenicity. Mol Cell Differ 1994, 2:247-371
15. De Benedetti A and Harris AL eIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 1999, 31:59-72
16. Sorrells DL, Meschonat C, Black D and Li BD Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor. J Surg Res 1999, 85:37-42
17. Li BD, McDonald JC, Nassar R and De Benedetti A Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. Ann Surg 1998, 227:756-756ldiscussion 761-753.
18. Rousseau D, Gingras AC, Pause A and Sonenberg N The eIF4Ebinding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996, 13:2415-2420
19. Martin ME, Perez MI, Redondo C, Alvarez MI, Salinas M and Fando JL 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol 2000, 32:633-642
20. Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG and Rhoads RE Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 1993, 55:841-847
21. Nathan CA, Carter P, Liu L, Li BD, Abreo F, Tudor A, Zimmer SG and De Benedetti A Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene 1997, 15:1087-1094
22. Hidalgo M and Rowinsky EK The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 2000, 19:6680-6686
23. Raught B, Gingras AC and Sonenberg N The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 2001, 98:7037-7044
24. Mothe-Satney I, Yang D, Fadden P, Haystead TA and Lawrence JC Jr Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol 2000, 20:3558-3567
25. Rousseau D, Kaspar R, Rosenwald I, Gehrke L and Sonenberg N Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci U S A 1996, 93:1065-1070
26. Long E, Lazaris-Karatzas A, Karatzas C and Zhao X Overexpressing eukaryotic translation initiation factor 4E stimulates bovine mammary epithelial cell proliferation. Int J Biochem Cell Biol 2001, 33:133-141
27. Sonenberg N mRNA 5′ cap-binding protein eIF4E and control of cell growth. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 1996,
28. Miskimins WK, Wang G, Hawkinson M and Miskimins R Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol Cell Biol 2001, 21:4960-4967
29. Coleman J, Hawkinson M, Miskimins R and Miskimins WK The major transcription initiation site of the p27Kip1 gene is conserved in human and mouse and produces a long 5′-UTR. BMC Mol Biol 2001, 2:12
30. Gan W, Celle ML and Rhoads RE Functional characterization of the internal ribosome entry site of eIF4G mRNA. J Biol Chem 1998, 273:5006-5012
31. Dostie J, Ferraiuolo M, Pause A, Adam SA and Sonenberg N A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5′ cap-binding protein, eIF4E. EMBO J 2000, 19:3142-3156
32. Cohen N, Sharma M, Kentsis A, Perez JM, Strudwick S and Borden KL PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J 2001, 20:4547-4559
33. Yu K, Toral-Barza L, Discafani C, Zhang WG, Skotnicki J, Frost P and Gibbons JJ mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 2001, 8:249-258
34. Hosoi H, Dilling MB, Liu LN, Danks MK, Shikata T, Sekulic A, Abraham RT, Lawrence JC Jr and Houghton PJ Studies on the mechanism of resistance to rapamycin in human cancer cells. Mol Pharmacol 1998, 54:815-824
35. Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC and Houghton PJ 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin. J Biol Chem 2002, 277:13907-13917
36. Beamish H, Williams R, Chen P, Khanna KK, Hobson K, Watters D, Shiloh Y and Lavin M Rapamycin resistance in ataxia-telangiectasia. Oncogene 1996, 13:963-970
37. Luo Y, Marx SO, Kiyokawa H, Koff A, Massague J and Marks AR Rapamycin resistance tied to defective regulation of p27Kip1. Mol Cell Biol 1996, 16:6744-6751
38. Ouyang Q, Bommakanti M and Miskimins WK A mitogen-responsive promoter region that is synergistically activated through multiple signalling pathways. Mol Cell Biol 1993, 13:1796-1804